386 related articles for article (PubMed ID: 37452943)
1. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract][Full Text] [Related]
2. Craniopharyngioma.
Müller HL; Merchant TE; Warmuth-Metz M; Martinez-Barbera JP; Puget S
Nat Rev Dis Primers; 2019 Nov; 5(1):75. PubMed ID: 31699993
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
[TBL] [Abstract][Full Text] [Related]
4. Craniopharyngiomas.
Karavitaki N; Cudlip S; Adams CB; Wass JA
Endocr Rev; 2006 Jun; 27(4):371-97. PubMed ID: 16543382
[TBL] [Abstract][Full Text] [Related]
5. Craniopharyngiomas.
Hamblin R; Tsermoulas G; Karavitaki N
Presse Med; 2021 Dec; 50(4):104078. PubMed ID: 34688870
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes in 31 patients with craniopharyngiomas extending outside the suprasellar cistern: an evaluation of the frontobasal interhemispheric approach.
Shirane R; Ching-Chan S; Kusaka Y; Jokura H; Yoshimoto T
J Neurosurg; 2002 Apr; 96(4):704-12. PubMed ID: 11990811
[TBL] [Abstract][Full Text] [Related]
7. Gamma Knife surgery for craniopharyngioma: report on a 20-year experience.
Lee CC; Yang HC; Chen CJ; Hung YC; Wu HM; Shiau CY; Guo WY; Pan DH; Chung WY; Liu KD
J Neurosurg; 2014 Dec; 121 Suppl():167-78. PubMed ID: 25434950
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
Brastianos PK; Taylor-Weiner A; Manley PE; Jones RT; Dias-Santagata D; Thorner AR; Lawrence MS; Rodriguez FJ; Bernardo LA; Schubert L; Sunkavalli A; Shillingford N; Calicchio ML; Lidov HG; Taha H; Martinez-Lage M; Santi M; Storm PB; Lee JY; Palmer JN; Adappa ND; Scott RM; Dunn IF; Laws ER; Stewart C; Ligon KL; Hoang MP; Van Hummelen P; Hahn WC; Louis DN; Resnick AC; Kieran MW; Getz G; Santagata S
Nat Genet; 2014 Feb; 46(2):161-5. PubMed ID: 24413733
[TBL] [Abstract][Full Text] [Related]
9. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
Erfurth EM
J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210
[TBL] [Abstract][Full Text] [Related]
10. [Etiology, Genetic Features and Clinical Presentations in Craniopharyngiomas].
Horiguchi K
No Shinkei Geka; 2023 Jul; 51(4):607-614. PubMed ID: 37491057
[TBL] [Abstract][Full Text] [Related]
11. Pediatric sellar tumors: diagnostic procedures and management.
Jagannathan J; Dumont AS; Jane JA; Laws ER
Neurosurg Focus; 2005 Jun; 18(6A):E6. PubMed ID: 16048292
[TBL] [Abstract][Full Text] [Related]
12. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
[TBL] [Abstract][Full Text] [Related]
13. Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma.
Gritsch D; Santagata S; Brastianos PK
Curr Treat Options Oncol; 2024 Feb; 25(2):261-273. PubMed ID: 38300480
[TBL] [Abstract][Full Text] [Related]
14. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
[TBL] [Abstract][Full Text] [Related]
15. Craniopharyngioma.
Garnett MR; Puget S; Grill J; Sainte-Rose C
Orphanet J Rare Dis; 2007 Apr; 2():18. PubMed ID: 17425791
[TBL] [Abstract][Full Text] [Related]
16. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.
Agosti E; Zeppieri M; Antonietti S; Piazza A; Ius T; Fontanella MM; Fiorindi A; Panciani PP
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255797
[TBL] [Abstract][Full Text] [Related]
17. Benefits of image-guided stereotactic hypofractionated radiation therapy as adjuvant treatment of craniopharyngiomas. A review.
Conti A; Pontoriero A; Ghetti I; Senger C; Vajkoczy P; Pergolizzi S; Germanò A
Childs Nerv Syst; 2019 Jan; 35(1):53-61. PubMed ID: 30151751
[TBL] [Abstract][Full Text] [Related]
18. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
19. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Weiner HL; Wisoff JH; Rosenberg ME; Kupersmith MJ; Cohen H; Zagzag D; Shiminski-Maher T; Flamm ES; Epstein FJ; Miller DC
Neurosurgery; 1994 Dec; 35(6):1001-10; discussion 1010-1. PubMed ID: 7885544
[TBL] [Abstract][Full Text] [Related]
20. Successful Use of BRAF/MEK Inhibitors as a Neoadjuvant Approach in the Definitive Treatment of Papillary Craniopharyngioma.
Khaddour K; Chicoine MR; Huang J; Dahiya S; Ansstas G
J Natl Compr Canc Netw; 2020 Dec; 18(12):1590-1595. PubMed ID: 33285519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
